Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination therapy
Biotech
Vir keeps pressure on Gilead with midphase hepatitis D data
Vir's hepatitis D therapy has shown efficacy in a phase 2 test, suggesting the cocktail may pose a threat to Gilead’s attempt in the market.
Nick Paul Taylor
Jun 5, 2024 8:52am
ASCO: Regeneron misses mark with one CR in solid tumor trial
May 23, 2024 5:00pm
Calliditas' cancer trial misses primary goal, hits on survival
May 7, 2024 6:39am
New immunotherapy drug design ups survival in mice with cancer
Apr 23, 2024 3:40am
Approved IBS drug may help overcome prostate cancer resistance
Jan 22, 2024 11:00am
First-in-class drug halts breast and ovarian cancer in mice
Oct 27, 2023 7:45am
